参考文献

[1]Anderson AW, Marinovich ML, Houssami N, et al. Independent external validation of artificial intelligence algorithms for automated interpretation of screening mammography: a systematic review. J Am Coll Radiol 2022; 

19: 259–73. 

[2]Dembrower K, Crippa A, Colón E, Eklund M, Strand F. Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study. Lancet Digit Health 2023; 5: e703–11. 

[3]Hernström V, Josefsson V, Sartor H, et al. Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallelgroup, non-inferiority, single-blinded, screening accuracy study. Lancet Digit Health 2025; published online Feb 3. https://doi.org/10.1016/S2589-7500(24)00267-X.

[4]Lång K, Josefsson V, Larsson A-M, et al. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. Lancet Oncol 2023; 24: 936–44. 

[5]Marinovich ML, Wylie E, Lotter W, et al. Artificial intelligence (AI) for breast cancer screening: BreastScreen population-based cohort study of cancer detection. EBioMedicine 2023; 90: 104498. 

[6]Jatoi I, Pinsky PF. Breast cancer screening trials: endpoints and overdiagnosis. J Natl Cancer Inst 2021; 113: 1131–35. 

[7]Hwang ES, Hyslop T, Lynch T, et al. Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial. JAMA 2024; published online Dec 12. https://doi.org/10.1001/jama.2024.26698.

[8]Carter SM, Popic D, Marinovich ML, Carolan L, Houssami N. Women’s views on using artificial intelligence in breast cancer screening: a review and qualitative study to guide breast screening services. Breast 2024; 77: 103783.